Neta Erez
Impact in
- Oncology top 0.5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Immunology top 1%
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
- Oncology 33
- Cancer Cells and Metastasis 15
- Cancer-related Molecular Pathways 7
- Cancer Immunotherapy and Biomarkers 6
- Chemokine receptors and signaling 5
- Co-authors
- Douglas Hanahan (3 shared papers)Lea Monteran (10 shared papers)Morgan Truitt (2 shared papers)Peter Olson (1 shared paper)Yael Raz (8 shared papers)Noam Cohen (12 shared papers)Michael Milyavsky (11 shared papers)Dor Lavie (2 shared papers)
- Journals
- Cancer Research (9 papers)Oncogene (4 papers)Oncotarget (3 papers)International Journal of Cancer (3 papers)Cancer Cell (2 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Neta Erez
64 papers receiving 5.8k citations
Neta Erez's Hit Papers
Peers
Comparison fields: 5 of 123
- Oncology 2.8k
- Immunology 1.8k
- Cancer Research 1.2k
- Molecular Biology 2.4k
- Biotechnology 250
Countries citing papers authored by Neta Erez
This map shows the geographic impact of Neta Erez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neta Erez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neta Erez more than expected).
Fields of papers citing papers by Neta Erez
This network shows the impact of papers produced by Neta Erez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neta Erez. The network helps show where Neta Erez may publish in the future.
Co-authors
The 25 scholars most cited alongside Neta Erez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner Hit paper breakdown → | 2010 | 1209 |
| 2 | The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment Hit paper breakdown → | 2019 | 524 |
| 3 | Cancer-associated fibroblasts in the single-cell era Hit paper breakdown → | 2022 | 402 |
| 4 | 2019 | 247 | |
| 5 | 2017 | 228 | |
| 6 | 2018 | 203 | |
| 7 | 2019 | 190 | |
| 8 | 2004 | 167 | |
| 9 | 2008 | 166 | |
| 10 | 2013 | 144 | |
| 11 | 2015 | 143 | |
| 12 | Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype. | 2003 | 134 |
| 13 | 2012 | 133 | |
| 14 | 2004 | 119 | |
| 15 | 2020 | 115 | |
| 16 | 2022 | 98 | |
| 17 | 2015 | 93 | |
| 18 | 2002 | 89 | |
| 19 | Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth. | 2003 | 89 |
| 20 | 2016 | 73 |
About Neta Erez
Neta Erez is a scholar working on Oncology, Molecular Biology, Immunology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 66 papers that have together received 5.9k indexed citations. Recurring topics across this work include Immune cells in cancer (16 papers), Cancer Cells and Metastasis (15 papers), Immunotherapy and Immune Responses (8 papers), Cancer-related Molecular Pathways (7 papers), Brain Metastases and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer, Stress, Anesthesia, and Immune Response (5 papers) and Chemokine receptors and signaling (5 papers). The work is most often cited by research in Oncology (2.8k citations), Immunology (1.8k citations), Cancer Research (1.2k citations), Molecular Biology (2.4k citations) and Biotechnology (250 citations). Neta Erez has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Douglas Hanahan, Lea Monteran, Morgan Truitt, Peter Olson, Yael Raz, Noam Cohen, Michael Milyavsky, Dor Lavie, Varda Rotter and Ruth Scherz‐Shouval. Their work appears in journals such as Cancer Research, Oncogene, Oncotarget, International Journal of Cancer and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.